Blog / Policy

ASC vs HOPD: How Reimbursement Differs for the Most Common Procedures

The rate gap between surgery centers and hospital outpatient departments is shrinking, and the 2026 and 2027 rules decide how fast.

ASC vs HOPD reimbursement explained: the 2026 rule, the covered procedures list, site neutrality, and what it means for your 2027 case mix.

ASC vs HOPD: How Reimbursement Differs for the Most Common Procedures

Why the same procedure pays differently in two settings

ASC vs HOPD reimbursement is not a close call: Medicare pays less for the same procedure in an ambulatory surgery center than it pays a hospital outpatient department, and CMS has built site-of-service policy around that gap for years. The CY2026 final rule added 560 procedures to the ASC covered list, 271 of them pulled from the inpatient only list, because the agency wants more cases moving to the lower-cost setting (CMS, November 2025).

The market is moving the same direction the rule is pushing it. The US ASC market was about $45.3 billion in 2025 and is projected to grow at a 6.1 percent compound rate through 2033, with about 6,400 Medicare-certified centers already operating (Grand View Research, 2025; MedPAC, 2026). For owners, administrators and surgical services leaders, the rate gap itself is not news. What is new is how much of your surgeons' current hospital volume is now payable in your building, and how fast hospitals are reacting as their own outpatient rates come under the same pressure that has always applied to yours.

What changed in the CY2026 rule, and what it means for 2027

The CY2026 rule is the most consequential ASC rule in a decade. ASC and hospital outpatient rates rose about 2.6 percent for centers that met quality reporting requirements (CMS, November 2025). CMS added 560 surgical procedures and 35 ancillary services to the ASC covered procedures list, and 271 of those additions came directly from the three-year phase-out of the inpatient only list, which started with musculoskeletal procedures under a new Level 7 payment classification.

That 2.6 percent is conditional, not automatic. The ASC Quality Reporting Program cuts the annual payment update by 2.0 percentage points for any center that does not meet reporting requirements (CMS). On a center doing several million dollars in net revenue, that is not a rounding error, and it is entirely avoidable with a calendar and an owner for the submission.

The CY2027 final rule follows the same November publication cycle. Confirm the conversion factor, any further additions to the covered list, and the next phase of the inpatient only phase-out before you finalize a 2027 budget. We walk through the full 2026 rule, procedure by procedure, in The CMS 2026 Final Rule for ASCs: 560 Procedures Added, the Inpatient Only List Phased Out.

Site neutrality is pulling HOPD rates toward ASC rates

Site neutral payment is the policy of paying the same rate for the same service no matter where it is performed. HOPD rates are generally higher than ASC rates for the same procedure today, and that gap is exactly what site neutrality is designed to close (MedPAC). The CY2026 rule expanded site neutrality for drug administration services in excepted off-campus hospital departments, paying them at the physician fee schedule rate instead of the higher hospital rate.

The direction matters more than any single year's number. Each rule cycle narrows the gap between HOPD and ASC payment, mostly by pushing hospital rates down rather than by raising ASC rates up. Hospital systems that depend on outpatient margin understand this, which is a large part of why they want ASC capacity of their own, through joint ventures or outright acquisition. It also means the hospital across town is not a static competitor. As its outpatient rates compress, it has more reason to either build ASC capacity or defend its outpatient volume on quality and convenience rather than price. We cover the mechanics and what it means for your negotiating position in Site Neutral Payments Explained for ASC Owners and Hospital CFOs.

ASC vs HOPD, by the numbers

The table below pulls together the policy and market facts that define the current gap between the two settings. None of these figures predict what any single procedure pays at any single payer. Use them to frame the conversation with your board or your surgeons, not to price a case.

ASC vs HOPD reimbursement and market context. Sources: CMS, November 2025; MedPAC, 2026; AHPA/NCSL, 2025; SIS, 2019.
ItemFigure
2026 payment update, quality reporters+2.6%
Payment update reduction for missed ASCQR reporting-2.0 percentage points
Procedures added to ASC covered list for 2026560 (271 from the inpatient only list)
Ancillary services added35
Medicare-certified ASCs in the USabout 6,400
States with some form of certificate of need requirement35 states plus DC
EBITDA margin, under $3M revenue vs over $9M revenue12.8% vs 37.3%

The spread in the last row is not a reimbursement fact, it is an operating fact, but it belongs next to the policy numbers because it shows where the real leverage sits. Two centers can be paid the identical ASC rate for the identical procedure and land 12.8 percent and 37.3 percent margins (Avanza). The rule changes open the door. What happens after you walk through it is cost control and scheduling discipline, not the fee schedule.

Where the ASC advantage is largest, and where it is not

Not every newly covered procedure is worth adding to your schedule, and the inpatient only phase-out is a good example of why. It started with musculoskeletal procedures, which is good news for orthopedic and spine centers, but those are also the procedures where supply cost runs near 30 percent of revenue because of implants (Avanza, 2022). A procedure that looks attractive on the Medicare fee schedule can still be a thin or negative contribution margin once the implant invoice is in.

Compare that to GI and ophthalmology procedures, where supply cost typically runs 12 to 15 percent of revenue. Those specialties rarely generate headlines in a covered-list update, but they are often the more predictable margin once staffing and turnover are accounted for. The fix for either kind of procedure is the same: cost it before you build a block around it. We cover implant and supply cost benchmarks by specialty in Supply Cost per Case by Specialty: Orthopedics, GI, Ophthalmology and Spine.

What this means for your case mix and contracting

Most commercial payers price ASC procedures as a percentage of the Medicare rate. A newly covered procedure with no existing commercial rate attached is not a payment, it is a negotiation, and the center that walks in with its own contribution margin data has the stronger position. The method is the same for every procedure, new or old: start from collections, capture what was actually consumed rather than what the preference card lists, load labor by minutes in the room, and spread fixed cost by scheduled room time. We lay out the full method in Case Costing for Surgery Centers.

Ownership and structure change how much of this work you do yourself. About 62 percent of ASC market revenue sits in physician-owned centers, with the remainder in hospital, corporate or joint venture structures (MedPAC, industry reports). Management companies commonly charge a fee in the range of 4 to 7 percent of net revenue in addition to an equity stake, which is worth weighing against what a center can accomplish with its own case cost data in hand (industry convention, commonly reported). And in the 35 states plus DC that run some form of certificate of need program, adding rooms or a new site to capture 2026 and 2027 covered procedures takes longer and can be contested by the local hospital, so confirm your state's CON rules before you build the pro forma, not after.

What to do this quarter

  1. Pull the 2026 covered procedures list against your surgeons' current hospital case logs and flag every procedure they already perform that is now payable in your center.
  2. Cost each flagged procedure using consumption data, not the preference card, before committing any block time to it. A procedure with a thin contribution margin does not improve by adding volume.
  3. Confirm your ASC Quality Reporting submissions are current for the measurement period tied to the 2027 update, since a missed submission costs the full year's payment increase.

Make your ASC more profitable

Sigmatic is a team of ASC consultants who use our own technology to manage surgery centers: better margins, better workflows, and a real-time view of cost per case and utilization that keeps the gains in place. If the numbers in this article look like your center, book a free 30-minute consultation and we will go through your own figures and show you where the margin is. Read the Case Costing for Surgery Centers guide, grab the free PDF, The 2027 ASC State of the Union: maximizing profit on razor-thin margins, from the form on this page, or email [email protected].

Free guide

The 2027 ASC State of the Union: Maximizing profit on razor-thin margins

16 pages of charts: the market, the 2026 reimbursement rules, the benchmarks that separate a 13 percent margin from a 37 percent one, a case costing method you can run this month and a 90-day plan.

One email with the PDF, then the occasional note on ASC margins. Unsubscribe any time.

Before you go

Want a more profitable ASC?

Book a free 30-minute consultation on your own numbers, or leave your email and we will send the 2027 guide first.

Make your ASC more profitable.

A free 30-minute consultation on your own numbers: where the margin is, what to fix first. No obligation.